Cargando…
Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum (II) and (IV) ammine/amine complexes.
Acquired resistance to cisplatin (cis-diamminedichloroplatinum (II)) has been generated in vitro in the 41M human ovarian carcinoma cell line, established from a previously untreated patient. Three cisplatin-resistant variants were selected at approximately 2, 4 and 6-fold resistance (in terms of 50...
Autores principales: | Loh, S. Y., Mistry, P., Kelland, L. R., Abel, G., Harrap, K. R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1978040/ https://www.ncbi.nlm.nih.gov/pubmed/1457352 |
Ejemplares similares
-
The cytotoxic action of four ammine/amine platinum(IV) dicarboxylates: a flow cytometric study.
por: Ormerod, M. G., et al.
Publicado: (1996) -
Lack of nephrotoxicity of oral ammine/amine platinum (IV) dicarboxylate complexes in rodents.
por: McKeage, M. J., et al.
Publicado: (1993) -
Mechanism of action of an orally administered platinum complex [ammine bis butyrato cyclohexylamine dichloroplatinum (IV) (JM221)] in intrinsically cisplatin-resistant human ovarian carcinoma in vitro.
por: McKeage, M. J., et al.
Publicado: (1994) -
Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.
por: Orr, R. M., et al.
Publicado: (1994) -
In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473.
por: Holford, J., et al.
Publicado: (1998)